» Articles » PMID: 21709159

The Tuberous Sclerosis Complex-mammalian Target of Rapamycin Pathway Maintains the Quiescence and Survival of Naive T Cells

Overview
Journal J Immunol
Date 2011 Jun 29
PMID 21709159
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Naive T cells receive stimulation from the positive selecting ligand in the periphery for their survival. This stimulation does not normally lead to overt activation of T cells, as the T cells remain largely quiescent until they receive either antigenic or lymphopenic stimuli. The underlying mechanism responsible for survival and quiescence of the naive T cells remains largely unknown. In this study, we report that T cell-specific deletion of Tsc1, a negative regulator of mammalian target of rapamycin, resulted in both spontaneous losses of quiescence and cellularity, especially within the CD8 subset. The Tsc1-deficient T cells have increased cell proliferation and apoptosis. Tsc1 deletion affects the survival and quiescence of T cells in the absence of antigenic stimulation. Loss of quiescence but not cellularity was inhibited by rapamycin. Our data demonstrate that tuberous sclerosis complex-mammalian target of rapamycin maintains quiescence and survival of T cells.

Citing Articles

Ndrg3 is a critical regulator of peripheral T cell maturation and homeostasis.

Komorowska J, Grammer C, Balan M, Swann J Sci Adv. 2025; 11(11):eads5143.

PMID: 40073135 PMC: 11900881. DOI: 10.1126/sciadv.ads5143.


Essential role of MFSD1-GLMP-GIMAP5 in lymphocyte survival and liver homeostasis.

Zhong X, Moresco J, Diedrich J, Pinto A, Sorelle J, Wang J Proc Natl Acad Sci U S A. 2023; 120(50):e2314429120.

PMID: 38055739 PMC: 10723049. DOI: 10.1073/pnas.2314429120.


Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.

Panwar V, Singh A, Bhatt M, Tonk R, Azizov S, Raza A Signal Transduct Target Ther. 2023; 8(1):375.

PMID: 37779156 PMC: 10543444. DOI: 10.1038/s41392-023-01608-z.


Signaling Pathways Leading to mTOR Activation Downstream Cytokine Receptors in Lymphocytes in Health and Disease.

Fallone L, Walzer T, Marcais A Int J Mol Sci. 2023; 24(16).

PMID: 37628917 PMC: 10454121. DOI: 10.3390/ijms241612736.


Absence of TSC1 Accelerates CD8 T cell-mediated Acute Cardiac Allograft Rejection.

Tan L, Xu Y, Lan G, Wang H, Liang Z, Zhang Z Aging Dis. 2022; 13(5):1562-1575.

PMID: 36186130 PMC: 9466980. DOI: 10.14336/AD.2022.0224.


References
1.
Polic B, Kunkel D, Scheffold A, Rajewsky K . How alpha beta T cells deal with induced TCR alpha ablation. Proc Natl Acad Sci U S A. 2001; 98(15):8744-9. PMC: 37506. DOI: 10.1073/pnas.141218898. View

2.
Lam K, Kuhn R, Rajewsky K . In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 1997; 90(6):1073-83. DOI: 10.1016/s0092-8674(00)80373-6. View

3.
Sancak Y, Peterson T, Shaul Y, Lindquist R, Thoreen C, Bar-Peled L . The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. 2008; 320(5882):1496-501. PMC: 2475333. DOI: 10.1126/science.1157535. View

4.
Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S . Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 2002; 110(2):177-89. DOI: 10.1016/s0092-8674(02)00833-4. View

5.
Delgoffe G, Kole T, Zheng Y, Zarek P, Matthews K, Xiao B . The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 2009; 30(6):832-44. PMC: 2768135. DOI: 10.1016/j.immuni.2009.04.014. View